Altered expression of microRNA during fracture healing in diabetic rats

Bone and Joint Research - Tập 7 Số 2 - Trang 139-147 - 2018
Shunsuke Takahara1,2,1,3,4, S. Y. Lee5,2,1,3,4, Takashi Iwakura1,2,1,3,4, Keisuke Oe1,2,1,3,4, Tomoaki Fukui1,2,1,3,4, Etsuko Okumachi1,2,1,3,4, Takahiro Waki1,2,1,3,4, Michio Arakura1,2,1,3,4, Yoshitada Sakai2,1,6,3,4, Kotaro Nishida1,2,1,3,4, Ryosuke Kuroda1,2,1,3,4, Takahiro Niikura1,2,1,3,4
1Department of Orthopaedic Surgery, Kobe University Graduate School of Medicine, 650-0017 Kobe, Japan
2Department of orthopaedic Surgery, Kobe university
3Division of Rehabilitation Medicine
4Graduate School of Medicine and Showa university School of Medicine, 650-0017 Kobe, Japan and 142-8666 Tokyo, Japan.
5Department of Orthopaedic Surgery, Kobe University Graduate School of Medicine and Showa University School of Medicine,650-0017 Kobe, Japan and 142-8666 Tokyo, Japan
6Division of Rehabilitation Medicine, Kobe University Graduate School of Medicine, 650-0017 Kobe, Japan

Tóm tắt

Objectives

Diabetes mellitus (DM) is known to impair fracture healing. Increasing evidence suggests that some microRNA (miRNA) is involved in the pathophysiology of diabetes and its complications. We hypothesized that the functions of miRNA and changes to their patterns of expression may be implicated in the pathogenesis of impaired fracture healing in DM.

Methods

Closed transverse fractures were created in the femurs of 116 rats, with half assigned to the DM group and half assigned to the control group. Rats with DM were induced by a single intraperitoneal injection of streptozotocin. At post-fracture days five, seven, 11, 14, 21, and 28, miRNA was extracted from the newly generated tissue at the fracture site. Microarray analysis was performed with miRNA samples from each group on post-fracture days five and 11. For further analysis, real-time polymerase chain reaction (PCR) analysis was performed at each timepoint.

Results

Microarray analysis showed that there were 14 miRNAs at day five and 17 miRNAs at day 11, with a greater than twofold change in the DM group compared with the control group. Among these types of miRNA, five were selected based on a comparative and extended literature review. Real-time PCR analysis revealed that five types of miRNA (miR-140-3p, miR-140-5p, miR-181a-1-3p, miR-210-3p, and miR-222-3p) were differentially expressed with changing patterns of expression during fracture healing in diabetic rats compared with controls.

Conclusions

Our findings provide information to further understand the pathology of impaired fracture healing in a diabetic rat model. These results may allow the potential development of molecular therapy using miRNA for the treatment of impaired fracture healing in patients with DM. Cite this article: S. Takahara, S. Y. Lee, T. Iwakura, K. Oe, T. Fukui, E. Okumachi, T. Waki, M. Arakura, Y. Sakai, K. Nishida, R. Kuroda, T. Niikura. Altered expression of microRNA during fracture healing in diabetic rats. Bone Joint Res 2018;7:139–147. DOI: 10.1302/2046-3758.72.BJR-2017-0082.R1.

Từ khóa


Tài liệu tham khảo

No authors listed. IDF Diabetes Atlas - 8th edition. http://www.diabetesatlas.org (date last accessed 24 November 2017).

10.1007/s11914-015-0286-8

Loder RT, 1988, Clin Orthop Relat Res, 232, 210, 10.1097/00003086-198807000-00028

10.3109/17453674.2012.747054

10.1302/0301-620X.89B12.19671

10.1016/j.bone.2008.07.246

10.1159/000218169

10.1007/s11914-013-0143-6

10.1186/s12891-016-0931-0

10.1002/jbmr.2040

10.1016/j.bone.2016.03.011

10.1302/0301-620X.97B8.34966

10.1002/jor.1100020115

10.1097/BOT.0b013e3181ca3f97

10.1016/j.bbrc.2011.07.048

10.1371/journal.pone.0058639

10.1016/j.febslet.2014.05.048

10.1089/ten.teb.2012.0116

10.1161/CIRCRESAHA.108.191270

10.1128/MCB.05178-11

10.1016/j.injury.2005.07.019

10.1016/j.bone.2005.09.015

10.1038/nrrheum.2012.1

10.1038/33429

10.1016/S0925-4773(99)00142-2

Portal-Núñez S, 2012, Histol Histopathol, 27, 559

10.1002/jbmr.2510

10.1074/jbc.M800731200

10.1016/j.tcm.2007.03.003

10.1177/0363546512458894

10.1182/blood-2006-01-012369

10.1038/sj.mt.6300311

Janssen HL, 2013, N Engl J Med, 369, 878

Wang S, 2014, Int J Clin Exp Pathol, 7, 2209

10.1007/s00223-017-0296-x

10.1258/ebm.2011.011207